Mycophenolate Mofetil in Idiopathic Membranous Nephropathy: A Clinical Trial With Comparison to a Historic Control Group Treated With Cyclophosphamide

American Journal of Kidney Diseases

Volumn 50, Issue 2, 2007, Pages 248-256

  Branten, Amanda J ^a   du Buf Vereijken, Peggy W ^a,b   Vervloet, Marc ^c   Wetzels, Jack F ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Immunosuppression; membranous nephropathy; mycophenolate mofetil; proteinuria; renal function decrease

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ANEMIA; ARTICLE; CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; INFECTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALAISE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PROTEINURIA; RELAPSE; REMISSION; RESPIRATORY TRACT INFECTION; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; CYCLOPHOSPHAMIDE; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROTEINURIA;

EID: 34447637101     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.05.015     Document Type: Article

References (26)

1. Haas M., Meehan S.M., Karrison T.G., and Spargo B.H. Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 30 (1997) 621-631
2. du Buf-Vereijken P.W.G., Branten A.J.W., and Wetzels J.F.M. Idiopathic membranous nephropathy: Outline and rationale of a treatment strategy. Am J Kidney Dis 46 (2005) 1012-1029
3. Branten A.J.W., Reichert L.J.M., Koene R.A.P., and Wetzels J.F.M. Oral cyclophosphamide versus chlorambucil in the treatment of patients with idiopathic membranous nephropathy and renal insufficiency. QJM 91 (1998) 359-366
4. Branten A.J.W., and Wetzels J.F.M. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Clin Nephrol 56 (2001) 1-8
5. du Buf-Vereijken P.W.G., Feith G.W., Hollander D., et al. Restrictive use of immunosuppressive treatment in patients with idiopathic membranous nephropathy: High renal survival in a large patient cohort. QJM 97 (2004) 353-360
6. du Buf-Vereijken P.W.G., Branten A.J.W., Wetzels J.F.M., and Membranous Nephropathy Study Group. Cytotoxic therapy for membranous nephropathy and renal insufficiency; Improved renal survival but high relapse rate. Nephrol Dial Transplant 19 (2004) 1142-1148
7. Jindal K., West M., Bear R., and Goldstein M. Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function. Am J Kidney Dis 19 (1992) 61-67
8. Falk R.J., Hogan S.L., Muller K.E., and Jennette J.C. Glomerular Disease Collaborative Network: Treatment of progressive membranous glomerulopathy. Ann Intern Med 116 (1992) 438-445
9. Stirling C.M., Simpson K., and Boulton-Jones J.M. Immunosuppression and outcome in idiopathic membranous nephropathy. QJM 9 (1998) 159-164
10. Torres A., Dominguez-Gil B., Carreno A., et al. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy. Kidney Int 61 (2002) 219-227
11. Cattran D.C. Cytotoxics, cyclosporine and membranous nephropathy. Curr Opin Nephrol Hypertens 5 (1996) 427-436
12. Honkanen E., Tornroth T., Gronhagen-Riska C., and Sankila R. Long-term survival in idiopathic membranous glomerulonephritis: Can the course be clinically predicted?. Clin Nephrol 41 (1994) 127-134
13. Davison A.M., Cameron J.S., Kerr D.N., Ogg C.S., and Wilkinson R.W. The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 22 (1984) 61-67
14. Reichert L.J.M., Koene R.A.P., and Wetzels J.F.M. Prognostic factors in idiopathic membranous nephropathy. Am J Kidney Dis 31 (1998) 1-11
15. Mathew T.H., and Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantion: Results at three years. Transplantation 65 (1998) 1450-1454
16. Chan T.M., Li F.K., Tang C.S.O., et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med 343 (2000) 1156-1162
17. Appel G.B., Radhakrishnan J., and Ginzler E.M. Use of mycophenolate mofetil in autoimmune and renal diseases. Transplantation 80 suppl 2 (2005) S265-S271
18. Wetzels J.F.M. Cyclophosphamide-induced gonadal toxicity: A treatment dilemma in patients with lupus nephritis?. Neth J Med 62 (2004) 347-352
19. Talar-Williams C., Hijazi Y.M., Walther M.M., et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 124 (1996) 477-484
20. Knight A., Askling J., Granath F., Sparen P., and Ekbom A. Urinary bladder cancer in Wegener's granulomatosis: Risk and relation to cyclophosphamide. Ann Rheum Dis 63 (2004) 1307-1311
21. Briggs W.A., Choi M.J., and Scheel Jr. P.J. Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis 31 (1998) 213-217
22. Choi M.J., Eustace J.A., Gimenez L.F., et al. Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 61 (2002) 1098-1114
23. Miller G., Zimmerman III R., Radhakrishnan J., and Appel G.B. Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kidney Dis 36 (2000) 250-256
24. Polenakovic M. Mycophenolate mofetil in treatment of idiopathic stages III-IV membranous nephropathy. Nephrol Dial Transplant 18 (2003) 1233-1234
25. Ponticelli C., Zucchelli P., Passerini P., Cesana B., and Italian Idiopathic Membranous Nephropathy Treatment Study Group. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N Engl J Med 327 (1992) 599-603
26. Ponticelli C., Altieri P., Scolari F., et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol 9 (1998) 444-450